Emily K Horn (Emily Horn)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Infectious Diseases

Top Venues

The Journal of infectious diseases

Infectious diseases and therapy

Expert review of vaccines

This page only lists publications with an associated author ORCID identifier.

Publications

Emily K Horn, Oscar Herrera Restrepo, Anna M Acosta, Alyssa Simon, Bianca Jackson, Eleanor Lucas
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies. The Journal of infectious diseases 230 (1) (2024)
Emily K Horn, Oscar Herrera Restrepo, Anna M Acosta, Alyssa Simon, Bianca Jackson, Eleanor Lucas
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies. The Journal of infectious diseases 230 (1) (2024)
Emily K Horn, Oscar Herrera Restrepo, Anna M Acosta, Alyssa Simon, Bianca Jackson, Eleanor Lucas
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies. The Journal of infectious diseases (2024)
Emily K Horn, Oscar Herrera Restrepo, Anna M Acosta, Alyssa Simon, Bianca Jackson, Eleanor Lucas
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies. The Journal of infectious diseases 230 (1) (2024)
Emily K Horn, Oscar Herrera Restrepo, Anna M Acosta, Alyssa Simon, Bianca Jackson, Eleanor Lucas
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies. The Journal of infectious diseases (2024)
Emily K Horn, Oscar Herrera Restrepo, Anna M Acosta, Alyssa Simon, Bianca Jackson, Eleanor Lucas
The Burden of Hepatitis A Outbreaks in the United States: Health Outcomes, Economic Costs, and Management Strategies. The Journal of infectious diseases (2024)
Johnna E Perdrizet, Emily K Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer M Nailes, Jaime Santos, Anna Ong-Lim
Response to Gomez et al.'s Letter to the Editor Regarding: "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants". Infectious diseases and therapy 11 (4) (2022)
Johnna E Perdrizet, Emily K Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer M Nailes, Jaime Santos, Anna Ong-Lim
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants". Infectious diseases and therapy 11 (3) (2022)
Johnna E Perdrizet, Raymond A Farkouh, Emily K Horn, Kyla Hayford, Heather L Sings, Matthew Wasserman
The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert review of vaccines 21 (4) (2022)
Canna Jagdish Ghia, Emily K Horn, Gautam Rambhad, Johnna E Perdrizet, Ramaa Chitale, Matthew Wasserman
Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India. Infectious diseases and therapy 10 (4) (2021)
Johnna E Perdrizet, Emily K Horn, Winniefer Nua, Judith Perez-Peralta, Jennifer M Nailes, Jaime Santos, Anna Ong-Lim
Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants. Infectious diseases and therapy 10 (4) (2021)
Emily K Horn, Matthew Wasserman, Cassandra K Hall-Murray, Heather L Sings, Ruth Chapman, Raymond A Farkouh
Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges. Expert review of vaccines 20 (10) (2021)
Matthew Wasserman, Johnna E Perdrizet, Lindsay Grant, Kyla Hayford, Shubhra Singh, Paranjoy Saharia, Emily K Horn, Raymond A Farkouh
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age. Infectious diseases and therapy 10 (4) (2021)